Heart rate variability and Omega-3 Index in euthymic patients with bipolar disorders

European Psychiatry

Volumn 30, Issue 2, 2015, Pages 228-232

  Voggt, A ^a   Berger, M ^a,b   Obermeier, M ^a,c   Low A ^a   Seemueller, F ^a,d   Riedel, M ^a,e   Moeller, H J ^a   Zimmermann, R ^a,d   Kirchberg, F ^a,f   Von Schacky, C ^a   Severus, E ^a,g  

^a UNIVERSITY OF MUNICH   (Germany)

^b Clienia Schlössli   (Switzerland)

^c Abteilung Biostatistik   (Germany)

^d Kbo Lech Mangfall Klinik   (Germany)

^e Vinzenz von Paul Hospital Rottweil   (Germany)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Bipolar disorder; Cardiovascular disease; Heart rate variability; Omega 3 Index

Indexed keywords

CAFFEINE; OMEGA 3 FATTY ACID;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BODY MASS; COMORBIDITY; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX; SMOKING; AGED; BIPOLAR DISORDER; BLOOD; HEART RATE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; BIPOLAR DISORDER; ELECTROCARDIOGRAPHY; FATTY ACIDS, OMEGA-3; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED;

EID: 84921265071     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2014.11.010     Document Type: Article

References (42)

1. Ali S., Garg S.K., Cohen B.E., Bhave P., Harris W.S., Whooley M.A. Association between omega-3 fatty acids and depressive symptoms among patients with established coronary artery disease: data from the Heart and Soul Study. Psychother Psychosom 2009, 78(2):125-127.
2. Amin A.A., Menon R.A., Reid K.J., Harris W.S., Spertus J.A. Acute coronary syndrome patients with depression have low blood cell membrane omega-3 fatty acid levels. Psychosom Med 2008, 70(8):856-862.
3. Baghai T.C., Varallo-Bedarida G., Born C., Hafner S., Schule C., Eser D., et al. Major depressive disorder is associated with cardiovascular risk factors and low Omega-3 Index. J Clin Psychiatry 2011, 72(9):1242-1247.
4. Berridge M.J. Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia. Prion 2013, 7(1):2-13.
5. Buccelletti E., Gilardi E., Scaini E., Galiuto L., Persiani R., Biondi A., et al. Heart rate variability and myocardial infarction: systematic literature review and meta-analysis. Eur Rev Med Pharmacol Sci 2009, 13(4):299-307.
6. Carney R.M., Freedland K.E., Veith R.C. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med 2005, 67(Suppl 1):S29-S33.
7. Carney R.M., Freedland K.E., Stein P.K., Steinmeyer B.C., Harris W.S., Rubin E.H., et al. Effect of omega-3 fatty acids on heart rate variability in depressed patients with coronary heart disease. Psychosom Med 2010, 72(8):748-754.
8. Chang H.A., Chang C.C., Tzeng N.S., Kuo T.B., Lu R.B., Huang S.Y. Heart rate variability in unmedicated patients with bipolar disorder in the manic phase. Psychiatry Clin Neurosci 2014, 68(9):674-682.
9. Chen P.S., Tan A.Y. Autonomic nerve activity and atrial fibrillation. Heart Rhythm 2007, 4(3 Suppl):S61-S64.
10. Christensen J.H. Omega-3 polyunsaturated fatty acids and heart rate variability. Front Physiol 2011, 2:84.
11. Cohen H., Kaplan Z., Kotler M., Mittelman I., Osher Y., Bersudsky Y. Impaired heart rate variability in euthymic bipolar patients. Bipolar Disord 2003, 5(2):138-143.
12. CPS GmbH. ProSciCard III. 12-11-2009. Ref Type: Online Source.
13. Eschweiler G.W., Bartels M., Langle G., Wild B., Gaertner I., Nickola M. Heart-rate variability (HRV) in the ECG trace of routine EEGs: fast monitoring for the anticholinergic effects of clozapine and olanzapine?. Pharmacopsychiatry 2002, 35(3):96-100.
14. Grosso G., Pajak A., Marventano S., Castellano S., Galvano F., Bucolo C., et al. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One 2014, 9(5):e96905.
15. Harris W.S., von S.C. The Omega-3 Index: a new risk factor for death from coronary heart disease?. Prev Med 2004, 39(1):212-220.
16. Huikuri H.V., Stein P.K. Heart rate variability in risk stratification of cardiac patients. Prog Cardiovasc Dis 2013, 56(2):153-159.
17. Jan W.C., Yang S.Y., Chuang L.C., Lu R.B., Lu M.K., Sun H.S., et al. Exploring the associations between genetic variants in genes encoding for subunits of calcium channel and subtypes of bipolar disorder. J Affect Disord 2014, 157:80-86.
18. Janney C.A., Fagiolini A., Swartz H.A., Jakicic J.M., Holleman R.G., Richardson C.R. Are adults with bipolar disorder active? Objectively measured physical activity and sedentary behavior using accelerometry. J Affect Disord 2014, 152-4:498-504.
19. Kilbourne A.M., Goodrich D.E., Lai Z., Post E.P., Schumacher K., Nord K.M., et al. Randomized controlled trial to assess reduction of cardiovascular disease risk in patients with bipolar disorder: the Self-Management Addressing Heart Risk Trial (SMAHRT). J Clin Psychiatry 2013, 74(7):e655-e662.
20. Lala S.V., Sajatovic M. Medical and psychiatric comorbidities among elderly individuals with bipolar disorder: a literature review. J Geriatr Psychiatry Neurol 2012, 25(1):20-25.
21. Laursen T.M. Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res 2011, 131(1-3):101-104.
22. Lee J.S., Kim B., Hong Y., Joo Y.H. Heart rate variability in the subsyndromal depressive phase of bipolar disorder. Psychiatry Clin Neurosci 2012, 66(4):361-366.
23. Linder J.R., Sodhi S.K., Haynes W.G., Fiedorowicz J.G. Effects of antipsychotic drugs on cardiovascular variability in participants with bipolar disorder. Hum Psychopharmacol 2014, 29(2):145-151.
24. Mann K., Rossbach W., Muller M.J., Muller-Siecheneder F., Ru H., Dittmann R.W. Heart rate variability during sleep in patients with schizophrenia treated with olanzapine. Int Clin Psychopharmacol 2004, 19(6):325-330.
25. Merikangas K.R., Jin R., He J.P., Kessler R.C., Lee S., Sampson N.A., et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011, 68(3):241-251.
26. Moon E., Lee S.H., Kim D.H., Hwang B. Comparative study of heart rate variability in patients with schizophrenia, bipolar disorder, post-traumatic stress disorder, or major depressive disorder. Clin Psychopharmacol Neurosci 2013, 11(3):137-143.
27. Mozaffarian D., Stein P.K., Prineas R.J., Siscovick D.S. Dietary fish and omega-3 fatty acid consumption and heart rate variability in US adults. Circulation 2008, 117(9):1130-1137.
28. Persons J.E., Robinson J.G., Ammann E.M., Coryell W.H., Espeland M.A., Harris W.S., et al. Omega-3 fatty acid biomarkers and subsequent depressive symptoms. Int J Geriatr Psychiatry 2014, 29(7):747-757.
29. Pfennig A., Bschor T., Baghai T., Braunig P., Brieger P., Falkai P., et al. [S3 guidelines on diagnostics and therapy of bipolar disorders: development process and essential recommendations]. Nervenarzt 2012, 83(5):568-586.
30. Pottala J.V., Talley J.A., Churchill S.W., Lynch D.A., von S.C., Harris W.S. Red blood cell fatty acids are associated with depression in a case-control study of adolescents. Prostaglandins Leukot Essent Fatty Acids 2012, 86(4-5):161-165.
31. Sarris J., Mischoulon D., Schweitzer I. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. J Clin Psychiatry 2012, 73(1):81-86.
32. Schueller P.O., Feuring M., Sharkova Y., Grimm W., Christ M. Effects of synthetic progestagens on autonomic tone, neurohormones and C-reactive protein levels in young healthy females in reproductive age. Int J Cardiol 2006, 111(1):42-48.
33. Severus W.E., Ahrens B., Stoll A.L. Omega-3 fatty acids: the missing link?. Arch Gen Psychiatry 1999, 56(4):380-381.
34. Slomka J.M., Piette J.D., Post E.P., Krein S.L., Lai Z., Goodrich D.E., et al. Mood disorder symptoms and elevated cardiovascular disease risk in patients with bipolar disorder. J Affect Disord 2012, 138(3):405-408.
35. Soreca I., Fagiolini A., Frank E., Houck P.R., Thompson W.K., Kupfer D.J. Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder. J Psychiatr Res 2008, 42(11):956-961.
36. Sublette M.E., Ellis S.P., Geant A.L., Mann J.J. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry 2011, 72(12):1577-1584.
37. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996, 17(3):354-381.
38. Tomson T., Ericson M., Ihrman C., Lindblad L.E. Heart rate variability in patients with epilepsy. Epilepsy Res 1998, 30(1):77-83.
39. Valenza G., Citi L., Gentili C., Lanata A., Scilingo E.P., Barbieri R. Point-process nonlinear autonomic assessment of depressive states in bipolar patients. Methods Inf Med 2014, 53(4):296-302.
40. von S.C. Omega-3 index and cardiovascular health. Nutrients 2014, 6(2):799-814.
41. Voss A., Baier V., Schulz S., Bar K.J. Linear and nonlinear methods for analyses of cardiovascular variability in bipolar disorders. Bipolar Disord 2006, 8(5 Pt 1):441-452.
42. Weiner M., Warren L., Fiedorowicz J.G. Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry 2011, 23(1):40-47.